NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









WuXi XDC Cayman Inc.

WuXi XDC Cayman Inc.

Public

WuXi XDC Cayman Inc. is now publicly traded

The data on this page reflects WuXi XDC Cayman Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Nov 17, 2023

Last Round

Follow-on Offering

Sep 3, 2025

Total Funding Raised

$1.02B

Company Overview

WuXi XDC Cayman Inc. is a publicly traded Contract Research, Development, and Manufacturing Organization (CRDMO) that specializes in bioconjugates, with a primary focus on Antibody-Drug Conjugates (ADCs). Spun off from WuXi Biologics, the company offers a comprehensive, single-source platform of services from discovery and process development to GMP manufacturing of bioconjugates, monoclonal antibody intermediates, and payload-linkers. The company operates globally with facilities in China (Wuxi, Shanghai, Changzhou) and is expanding with a new site in Singapore to implement a "global dual sourcing" strategy. WuXi XDC was established as a joint venture in 2021 and went public on the Hong Kong Stock Exchange (stock code: 2268.HK) in November 2023.

AI Layer

Non-AI

Keywords

antibody-drug conjugate (ADC) CRDMOend-to-end bioconjugate servicesbioconjugate contract manufacturingsingle-source ADC development platformGMP bioconjugate manufacturingpayload and linker development and manufacturingaseptic fill and finish servicesmonoclonal antibody intermediate manufacturingbioconjugation process developmentanalytical development for bioconjugatesglobal dual-sourcing for biopharma

WuXi XDC Cayman Inc. Comparables

Compare WuXi XDC Cayman Inc. with similar companies based on industry and business-model similarity.

WuXi XDC Cayman Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

WuXi XDC Cayman Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Follow-on OfferingSep 3, 2025
IPONov 17, 2023
Corporate FundingMay 14, 2021

WuXi XDC Cayman Inc. Investors

Notable investors and investment history

WuXi XDC Cayman Inc. investors
InvestorRounds
Credit Suisse Asset ManagementIPO
WuXi STACorporate Funding
General AtlanticIPO
Qatar Investment AuthorityIPO

WuXi XDC Cayman Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

WuXi XDC Cayman Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters
Employee Range301
Year Founded2021
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.